Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Wright

Showing results (181-190 of 510) with videos related to

Pageof 51
Sort By:
BMC Medicine|July 27, 2023
Why estimands are needed to define treatment effects in clinical trialsOliver N Keene, Helle Lynggaard, Stefan Englert, et al.
Archives of Orthopaedic and Trauma Surgery|October 5, 2017
Pain catastrophizing as a predictor for postoperative pain and opiate consumption in total joint arthroplasty patientsDavid Wright, Melinda Hoang, Anna Sofine, et al.
British Journal of Clinical Pharmacology|September 14, 2017
Renal function monitoring in heart failure - what is the optimal frequency? A narrative reviewAhmed Al-Naher, David Wright, Mark Alexander John Devonald, et al.
American Journal of Obstetrics and Gynecology|November 11, 2018
Two-stage screening for preterm preeclampsia at 11-13 weeks' gestationAlan Wright, David Wright, Argyro Syngelaki, et al.
Fetal Diagnosis and Therapy|August 22, 2012
Competing risks model in early screening for preeclampsia by biophysical and biochemical markersRanjit Akolekar, Argyro Syngelaki, Leona Poon, et al.
American Journal of Obstetrics and Gynecology|January 3, 2023
Personalized stratification of pregnancy care for small for gestational age neonates from biophysical markers at midgestationIoannis Papastefanou, David Wright, Argyro Syngelaki, et al.
Phytotherapy Research : PTR|March 18, 2011
Stable molluscicide formulation of an aqueous extract of Euphorbia myrsinitesAsmita V Patel, David Wright, Gerald Blunden, et al.
Fetal Diagnosis and Therapy|March 2, 2012
Temporal effect of Afro-Caribbean race on serum pregnancy-associated plasma protein-a at 9-13 weeks' gestation in screening for aneuploidiesSusan Ball, David Wright, Danielle Sodre, et al.
Journal of Vascular Surgery. Venous and Lymphatic Disorders|March 20, 2016
Assessment of thrombotic adverse events and treatment patterns associated with varicose vein treatmentThomas F O'Donnell, Michael Eaddy, Aditya Raju, et al.
American Journal of Obstetrics and Gynecology|February 16, 2016
Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 30-34 weeks' gestationAndreas Tsiakkas, Youssef Saiid, Alan Wright, et al.
Pageof 51

Showing results (181-190 of 510) with videos related to

Sort By:
Pageof 51
BMC Medicine|July 27, 2023
Why estimands are needed to define treatment effects in clinical trialsOliver N Keene, Helle Lynggaard, Stefan Englert, et al.
Archives of Orthopaedic and Trauma Surgery|October 5, 2017
Pain catastrophizing as a predictor for postoperative pain and opiate consumption in total joint arthroplasty patientsDavid Wright, Melinda Hoang, Anna Sofine, et al.
British Journal of Clinical Pharmacology|September 14, 2017
Renal function monitoring in heart failure - what is the optimal frequency? A narrative reviewAhmed Al-Naher, David Wright, Mark Alexander John Devonald, et al.
American Journal of Obstetrics and Gynecology|November 11, 2018
Two-stage screening for preterm preeclampsia at 11-13 weeks' gestationAlan Wright, David Wright, Argyro Syngelaki, et al.
Fetal Diagnosis and Therapy|August 22, 2012
Competing risks model in early screening for preeclampsia by biophysical and biochemical markersRanjit Akolekar, Argyro Syngelaki, Leona Poon, et al.
American Journal of Obstetrics and Gynecology|January 3, 2023
Personalized stratification of pregnancy care for small for gestational age neonates from biophysical markers at midgestationIoannis Papastefanou, David Wright, Argyro Syngelaki, et al.
Phytotherapy Research : PTR|March 18, 2011
Stable molluscicide formulation of an aqueous extract of Euphorbia myrsinitesAsmita V Patel, David Wright, Gerald Blunden, et al.
Fetal Diagnosis and Therapy|March 2, 2012
Temporal effect of Afro-Caribbean race on serum pregnancy-associated plasma protein-a at 9-13 weeks' gestation in screening for aneuploidiesSusan Ball, David Wright, Danielle Sodre, et al.
Journal of Vascular Surgery. Venous and Lymphatic Disorders|March 20, 2016
Assessment of thrombotic adverse events and treatment patterns associated with varicose vein treatmentThomas F O'Donnell, Michael Eaddy, Aditya Raju, et al.
American Journal of Obstetrics and Gynecology|February 16, 2016
Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 30-34 weeks' gestationAndreas Tsiakkas, Youssef Saiid, Alan Wright, et al.
Pageof 51